己糖激酶2(HK2)活性蛋白
Active Hexokinase 2 (HK2)
HK II; Muscle form hexokinase
- 編號(hào)APD352Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)5.5
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià)
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
![](http://static.cloud-clone.cn/product/pictures/APD352Hu01-202411191622024785.png)
Hexokinase 2 (HK2), also referred to as Hexokinase type II or Muscle form hexokinase, is an enzyme that belongs to the hexokinase family. This protein is widely expressed in a variety of tissues, especially in muscle and heart, and is highly expressed in many types of cancer .HK2 is a multifaceted enzyme that is essential for glucose metabolism and has been implicated in a wide range of cellular processes and diseases, including cancer and immune regulation.Besides,Hexokinase 1 (HK1) has been identified as an interactor of HK2, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human HK2 and recombinant human HK1.Briefly, HK2 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to HK1-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-HK2 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630nm immediately. The binding activity of recombinant human HK2 and recombinant human HK1 was shown in Figure 1, the EC50?for this effect is 0.12ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPD352Hu01 | 己糖激酶2(HK2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPD352Hu02 | 己糖激酶2(HK2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APD352Hu01 | 己糖激酶2(HK2)活性蛋白 | Cell?culture;?Activity?Assays. |
PAD352Hu01 | 己糖激酶2(HK2)多克隆抗體 | WB; IHC; ICC; IP. |
PAD352Hu02 | 己糖激酶2(HK2)多克隆抗體 | WB; IHC; ICC; IP; FCM |
MAD352Hu21 | 己糖激酶2(HK2)單克隆抗體 | WB; IHC; ICC; IP. |
SED352Hu | 己糖激酶2(HK2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMD352Hu | 己糖激酶2(HK2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Anti-Cancer Drugs | 3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2. [10.1097/CAD.0000000000000502] |
Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC) [] | |
J Cell Mol Med | Huaier shows anti?\cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF?\1|á pathway [33377619] |